Skip to main content

RETRACTION article

Front. Immunol., 16 July 2019
Sec. Cancer Immunity and Immunotherapy
Volume 10 - 2019 | https://doi.org/10.3389/fimmu.2019.01770

Retraction: Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells

This article is a retraction of:

  1. RETRACTED: Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells

    1. Read original article
\nFrontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells

by Zhu, L., Oh, J. M., Gangadaran, P., Kalimuthu, S., Baek, S. H., Jeong, S. Y., et al. (2018). Front. Immunol. 9:824. doi: 10.3389/fimmu.2018.00824

The journal and Chief Editors retract the April 2018 article cited above. Following the publication of the article, concerns regarding the results were addressed to the journal and its Editorial Board. Following clarification with the authors, errors were identified with the data and the article is therefore retracted with the agreement of the authors.

Citation: Frontiers Editorial Office (2019) Retraction: Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells. Front. Immunol. 10:1770. doi: 10.3389/fimmu.2019.01770

Received: 12 July 2019; Accepted: 12 July 2019;
Published: 16 July 2019.

Approved by:

Catherine Sautes-Fridman, INSERM U1138 Centre de Recherche des Cordeliers, France

Copyright © 2019 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.